Published in Gut on September 14, 2005
SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis | NCT04398550
From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology (2009) 1.96
The gut microbiota and host health: a new clinical frontier. Gut (2015) 1.91
Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol (2011) 1.65
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 1.25
Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'. Br J Clin Pharmacol (2008) 1.18
Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide. J Mol Histol (2010) 1.05
Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci Rep (2015) 1.03
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol (2014) 1.01
Immune modulation by different types of β2→1-fructans is toll-like receptor dependent. PLoS One (2013) 1.00
Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med (2013) 0.98
Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol (2006) 0.96
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int (2013) 0.95
Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists. Periodontol 2000 (2007) 0.92
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol (2014) 0.92
Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig Dis Sci (2007) 0.91
Crohn's disease as an immunodeficiency. Expert Rev Clin Immunol (2010) 0.89
Multiple omics uncovers host-gut microbial mutualism during prebiotic fructooligosaccharide supplementation. DNA Res (2014) 0.89
Prebiotics in chronic intestinal inflammation. Inflamm Bowel Dis (2009) 0.88
Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease? Front Med (Lausanne) (2014) 0.86
Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling. J Clin Invest (2012) 0.84
In vitro fermentation of sugar beet arabino-oligosaccharides by fecal microbiota obtained from patients with ulcerative colitis to selectively stimulate the growth of Bifidobacterium spp. and Lactobacillus spp. Appl Environ Microbiol (2011) 0.84
The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol (2016) 0.84
Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases. PPAR Res (2012) 0.83
Emergent Sources of Prebiotics: Seaweeds and Microalgae. Mar Drugs (2016) 0.82
Dietary fiber information for individuals with Crohn disease: reports of gastrointestinal effects. Gastroenterol Nurs (2013) 0.81
A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology (2012) 0.80
Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial. Clin Transl Gastroenterol (2013) 0.80
Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol (2015) 0.80
Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. Int J Mol Sci (2016) 0.79
Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum". Int J Inflam (2012) 0.79
Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol (2016) 0.79
Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation. Curr Hematol Malig Rep (2016) 0.78
Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease. Int J Mol Sci (2016) 0.76
The importance of appropriate initial bacterial colonization of the intestine in newborn, child and adult health. Pediatr Res (2017) 0.76
Integrative medicine and human health - the role of pre-, pro- and synbiotics. Clin Transl Med (2012) 0.76
An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention. Nutrients (2016) 0.75
Study of enzymatic hydrolysis of fructans from Agave salmiana characterization and kinetic assessment. ScientificWorldJournal (2012) 0.75
Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol (2017) 0.75
The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond. Visc Med (2017) 0.75
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients (2017) 0.75
Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol (1990) 34.40
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
A simple index of Crohn's-disease activity. Lancet (1980) 11.12
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol (2001) 11.07
Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (2004) 8.68
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med (2001) 8.60
Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology (1996) 8.59
Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol (1998) 8.56
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol (1995) 7.57
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut (2003) 5.19
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology (2004) 5.19
Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology (1999) 5.03
Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology (1995) 3.26
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology (2002) 2.80
Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med (2002) 2.78
Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology (2003) 2.59
Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis (2005) 2.47
Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol (2002) 2.45
Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29
Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology (2005) 2.25
Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut (1991) 2.24
Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol (1998) 2.01
The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut (2003) 1.84
Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64
Role of the faecal stream in the maintenance of Crohn's colitis. Gut (1985) 1.63
Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis (2000) 1.55
A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease. Gastroenterology (2004) 1.51
Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut (2004) 1.41
On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr (1995) 1.32
Intestinal microflora in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol (2001) 1.30
A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol (2001) 1.23
Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol (2002) 1.17
Gastrointestinal effects of prebiotics. Br J Nutr (2002) 1.08
Open label trial of oral clarithromycin in active Crohn's disease. Aliment Pharmacol Ther (2000) 1.08
Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increases energy excretion in ileostomy subjects. Eur J Clin Nutr (1997) 0.91
Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation. Biochem Biophys Res Commun (2002) 0.89
Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system. Appl Environ Microbiol (2004) 0.88
Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats. Scand J Gastroenterol (2002) 0.84
Response to faecal challenge in defunctioned colonic Crohn's disease: prediction of long-term course. Br J Surg (1990) 0.80
Effect of resistant starch on breath-hydrogen and methane excretion in healthy volunteers. Am J Clin Nutr (1994) 0.77
The all-or-nothing response of sensory nerve fibres. J Physiol (1922) 12.37
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol (2001) 7.43
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
Persistent pain and faecal urgency after stapled haemorrhoidectomy. Lancet (2000) 7.09
Anal-sphincter disruption during vaginal delivery. N Engl J Med (1993) 5.74
Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet (2004) 5.18
Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med (1987) 5.14
Neuraxial block, death and serious cardiovascular morbidity in the POISE trial. Br J Anaesth (2013) 4.60
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Prospective comparison of faecal incontinence grading systems. Gut (1999) 3.48
Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology (1986) 3.25
Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16
Systematic review of randomised controlled trials of interventions for painful shoulder: selection criteria, outcome assessment, and efficacy. BMJ (1998) 3.15
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01
Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ (1991) 2.94
Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut (2004) 2.92
Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair. BMJ (1994) 2.75
Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology (1986) 2.72
Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood (1990) 2.68
Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A (1983) 2.68
Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology (1990) 2.58
Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial. Ann Rheum Dis (2004) 2.54
Role of veiled cells in lymphocyte activation. Eur J Immunol (1982) 2.50
The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43
Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol (1987) 2.38
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet (1997) 2.38
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut (2005) 2.36
Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29
Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ (1994) 2.25
Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20
Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med (2001) 2.19
Effect of nitrous oxide on plasma homocysteine and folate in patients undergoing major surgery. Br J Anaesth (2008) 2.18
Is the multidisciplinary team essential for the future management of patients with inflammatory bowel disease? Colorectal Dis (2007) 2.14
Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther (2014) 2.11
Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther (2012) 2.11
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09
Gender differences in knee cartilage volume as measured by magnetic resonance imaging. Osteoarthritis Cartilage (1999) 2.06
AGA technical review on anorectal testing techniques. Gastroenterology (1999) 2.05
Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet (1994) 2.04
A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine (1995) 2.03
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut (1993) 2.01
Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol (1999) 2.01
Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis. J Crohns Colitis (2012) 2.00
Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol (1993) 2.00
Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99
Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut (2003) 1.98
Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J Med Genet (2007) 1.97
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut (2003) 1.95
The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry (2002) 1.90
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Veiled cells--"dendritic cells" of the peripheral lymph. Immunobiology (1984) 1.86
Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg (2004) 1.84
The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut (2003) 1.84
A standardized protocol for measurement of range of movement of the shoulder using the Plurimeter-V inclinometer and assessment of its intrarater and interrater reliability. Arthritis Care Res (1998) 1.83
Limited availability and higher cost of gluten-free foods. J Hum Nutr Diet (2011) 1.81
Long-term clinical outcome of surgery for solitary rectal ulcer syndrome. Br J Surg (1998) 1.80
Pilot study of two new injectable bulking agents for the treatment of faecal incontinence. Colorectal Dis (2007) 1.78
Pneumatosis coli: a proposed pathogenesis based on study of 25 cases and review of the literature. Int J Colorectal Dis (1996) 1.77
Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis (2009) 1.75
Permanent sacral nerve stimulation for treatment of idiopathic constipation. Br J Surg (2002) 1.75
Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut (2001) 1.75
Bowel dysfunction in spinal-cord-injury patients. Lancet (1996) 1.74
Comparison of occupational exposure using three different methods: hygiene panel, job exposure matrix (JEM), and self reports. Appl Occup Environ Hyg (2001) 1.74
Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther (2003) 1.73
Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma. Lancet (2000) 1.72
Complications and mortality in older surgical patients in Australia and New Zealand (the REASON study): a multicentre, prospective, observational study. Anaesthesia (2010) 1.72
Spatially restricted activity of a Drosophila lipid phosphatase guides migrating germ cells. Development (2001) 1.72
Effectiveness of intermediate care in nursing-led in-patient units. Cochrane Database Syst Rev (2007) 1.72
Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut (1997) 1.71
Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut (1993) 1.71
Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ (1995) 1.70
Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun (2000) 1.70
A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine (1997) 1.70
Prevalence and residential determinants of fungi within homes in Melbourne, Australia. Clin Exp Allergy (1999) 1.69
Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. Lancet (2000) 1.69
Endoscopic stenting for long-term treatment of large bile duct stones: 2- to 5-year follow-up. Gastrointest Endosc (1987) 1.69
Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg (1998) 1.68
Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet (2011) 1.68
Haemorrhoids: pathology, pathophysiology and aetiology. Br J Surg (1994) 1.67
Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture. J Immunol Methods (1980) 1.66
An 11-year experience of enterocutaneous fistula. Br J Surg (2004) 1.65
Micronutrient status in patients receiving home parenteral nutrition. Nutrition (1998) 1.64
Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64
The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther (2007) 1.64
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut (2004) 1.63
The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell Immunol (1985) 1.62
Systematic review: the effect of prunes on gastrointestinal function. Aliment Pharmacol Ther (2014) 1.62
Telephone follow-up to improve glycaemic control in patients with Type 2 diabetes: systematic review and meta-analysis of controlled trials. Diabet Med (2010) 1.62
Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg (2000) 1.61
Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol (1994) 1.61